Christopher C. Caillouet

Array ( [id] => 9074616 [patent_doc_number] => 08552194 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-08 [patent_title] => 'Process for preparing quinoline-3-carboxamide derivatives' [patent_app_type] => utility [patent_app_number] => 12/989796 [patent_app_country] => US [patent_app_date] => 2009-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4998 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12989796 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8846466 [patent_doc_number] => 08455648 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-04 [patent_title] => '1-(7-(hexahydropyrrolo [3,4-c] pyrrol-2 (1H)-yl) quinolin-4-yl) -3- (pyrazin-2-yl) urea derivatives and related compounds as glycogen synthase kinase 3 (GSK-3)' [patent_app_type] => utility [patent_app_number] => 12/988833 [patent_app_country] => US [patent_app_date] => 2009-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17914 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12988833 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8458246 [patent_doc_number] => 08293914 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-23 [patent_title] => '4-OXO,1-4-dihydroquinoline M1 receptor positive allosteric modulators' [patent_app_type] => utility [patent_app_number] => 12/990014 [patent_app_country] => US [patent_app_date] => 2009-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15018 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12990014 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8784861 [patent_doc_number] => 08431704 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-30 [patent_title] => 'Quinoline or isoquinoline substituted P2X7 antagonists' [patent_app_type] => utility [patent_app_number] => 12/988891 [patent_app_country] => US [patent_app_date] => 2009-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48710 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12988891 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8527857 [patent_doc_number] => 08304427 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-06 [patent_title] => 'Acylthiourea compound or salt thereof, and use thereof' [patent_app_type] => utility [patent_app_number] => 12/937312 [patent_app_country] => US [patent_app_date] => 2009-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 22492 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12937312 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6196968 [patent_doc_number] => 20110028726 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'METHOD FOR PREPARING ARGATROBAN MONOHYDRATE AND A PROCESS FOR ITS SYNTHESIS' [patent_app_type] => utility [patent_app_number] => 12/935512 [patent_app_country] => US [patent_app_date] => 2009-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 6727 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20110028726.pdf [firstpage_image] =>[orig_patent_app_number] => 12935512 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5930323 [patent_doc_number] => 20110040095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-17 [patent_title] => 'PREPARATION OF MONTELUKAST AND ITS SALTS' [patent_app_type] => utility [patent_app_number] => 12/921618 [patent_app_country] => US [patent_app_date] => 2009-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8379 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20110040095.pdf [firstpage_image] =>[orig_patent_app_number] => 12921618 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8317625 [patent_doc_number] => 08232402 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-31 [patent_title] => 'Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications' [patent_app_type] => utility [patent_app_number] => 12/402910 [patent_app_country] => US [patent_app_date] => 2009-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 36 [patent_no_of_words] => 36869 [patent_no_of_claims] => 90 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12402910 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5954820 [patent_doc_number] => 20110034692 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'SPECIFIC IMPURITIES OF MONTELUKAST' [patent_app_type] => utility [patent_app_number] => 12/922267 [patent_app_country] => US [patent_app_date] => 2009-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10438 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20110034692.pdf [firstpage_image] =>[orig_patent_app_number] => 12922267 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5386383 [patent_doc_number] => 20090227628 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-10 [patent_title] => '2-AMINOQUINOLINES' [patent_app_type] => utility [patent_app_number] => 12/394083 [patent_app_country] => US [patent_app_date] => 2009-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9479 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20090227628.pdf [firstpage_image] =>[orig_patent_app_number] => 12394083 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4609851 [patent_doc_number] => 07994324 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-09 [patent_title] => '2-aminoquinoline derivatives' [patent_app_type] => utility [patent_app_number] => 12/394092 [patent_app_country] => US [patent_app_date] => 2009-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12174 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/994/07994324.pdf [firstpage_image] =>[orig_patent_app_number] => 12394092 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8202113 [patent_doc_number] => 08188284 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-29 [patent_title] => '2-aminoquinolines' [patent_app_type] => utility [patent_app_number] => 12/394072 [patent_app_country] => US [patent_app_date] => 2009-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18116 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/188/08188284.pdf [firstpage_image] =>[orig_patent_app_number] => 12394072 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7740784 [patent_doc_number] => 08106072 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-31 [patent_title] => '7- (4-substituted-3-cyclopropylaminomethyl-1-pyrrolidinyl) quinolonecarboxylic acid derivative' [patent_app_type] => utility [patent_app_number] => 12/379699 [patent_app_country] => US [patent_app_date] => 2009-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23436 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/106/08106072.pdf [firstpage_image] =>[orig_patent_app_number] => 12379699 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8189676 [patent_doc_number] => 08183380 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-22 [patent_title] => '2-aminoquinolines' [patent_app_type] => utility [patent_app_number] => 12/393058 [patent_app_country] => US [patent_app_date] => 2009-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34848 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/183/08183380.pdf [firstpage_image] =>[orig_patent_app_number] => 12393058 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 92558 [patent_doc_number] => 07737282 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-15 [patent_title] => 'Benzimidazole compound crystal' [patent_app_type] => utility [patent_app_number] => 12/393409 [patent_app_country] => US [patent_app_date] => 2009-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7183 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/737/07737282.pdf [firstpage_image] =>[orig_patent_app_number] => 12393409 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5436309 [patent_doc_number] => 20090170896 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'c-Met modulators and methods of use' [patent_app_type] => utility [patent_app_number] => 12/393806 [patent_app_country] => US [patent_app_date] => 2009-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 83626 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20090170896.pdf [firstpage_image] =>[orig_patent_app_number] => 12393806 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5539830 [patent_doc_number] => 20090221635 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'QUINOLINYL AND BENZOTHIAZOLYL MODULATORS' [patent_app_type] => utility [patent_app_number] => 12/372699 [patent_app_country] => US [patent_app_date] => 2009-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44592 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20090221635.pdf [firstpage_image] =>[orig_patent_app_number] => 12372699 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7730264 [patent_doc_number] => 08101766 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-24 [patent_title] => 'Crystalline form of a biphenyl compound' [patent_app_type] => utility [patent_app_number] => 12/369605 [patent_app_country] => US [patent_app_date] => 2009-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 22079 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/101/08101766.pdf [firstpage_image] =>[orig_patent_app_number] => 12369605 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4478521 [patent_doc_number] => 07906650 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-15 [patent_title] => 'Caspase inhibitors and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/359749 [patent_app_country] => US [patent_app_date] => 2009-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19086 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/906/07906650.pdf [firstpage_image] =>[orig_patent_app_number] => 12359749 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6026128 [patent_doc_number] => 20110053935 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'FUSED PYRIDINES ACTIVE AS INHIBITORS OF C-MET' [patent_app_type] => utility [patent_app_number] => 12/864112 [patent_app_country] => US [patent_app_date] => 2009-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12764 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20110053935.pdf [firstpage_image] =>[orig_patent_app_number] => 12864112 [rel_patent_id] =>[rel_patent_doc_number] =>)